Micromet(德國(guó))
Micromet
德國(guó)Micromet www.micromet.deMicromet創(chuàng)建于德國(guó),總部現(xiàn)設(shè)在馬里蘭州的Rockville,該公司正在開(kāi)發(fā)一款試驗(yàn)性血癌治療藥物,目前處在中期試驗(yàn)階段。Micrometwasfoundedin1993byasmallteamofentrepreneurialscientistsfromtheUniversityofMunichwithafirmbeliefinthepo
tentialofTcellbasedtherapiestotreatcancer.TheirvisionwastodevelopanewclassofdrugsthatmobilizeTcells,thebody'smostpotentkillercells,enablingthemtodetectanddestroynormallyunrecognizablecancercells.Withinafewshortyears,theCompanydemonstratedtheclinicalpotentialofitstechnology,referredtoasBiTE®(Bi-specificTcellengager),withthepublicationofcompellingresultsfromaPhase1trialofitsBiTEantibodyBlinatumomab(MT103)inpatientswithnon-Hodgkin'slymphoma.MicrometbegantradingontheNasdaqGlobalMarketunderthesymbolMITIfollowingaMay2006reversemergerwithCalifornia-basedCancerVax.TodayMicrometisanintegratedbiopharmaceuticalcompanywitha